Skip to main content
Kate Lathrop, MD, Oncology, San Antonio, TX

KateI.LathropMD

Oncology San Antonio, TX

Physician

Dr. Lathrop is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Lathrop's full profile

Already have an account?

  • Office

    7979 Wurzbach Rd
    San Antonio, TX 78229
    Phone+1 210-450-1143
    Fax+1 210-450-0407

Education & Training

  • University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
    University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 2011 - 2014
  • University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
    University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 2007 - 2010
  • The University of Texas Health Science Center at San Antonio
    The University of Texas Health Science Center at San AntonioClass of 2007

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2009 - 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Risk-Reducing Surgeries Improve Survival for Younger Patients with Breast Cancer Who Are BRCA Carriers, Study Finds
    Risk-Reducing Surgeries Improve Survival for Younger Patients with Breast Cancer Who Are BRCA Carriers, Study FindsJanuary 25th, 2025
  • OlympiA Trial: Long-Term Benefits of Olaparib Confirmed in High-Risk Subgroup of Breast Cancer
    OlympiA Trial: Long-Term Benefits of Olaparib Confirmed in High-Risk Subgroup of Breast CancerJanuary 25th, 2025
  • Imlunestrant Combo Improves PFS in Advanced Breast Cancer
    Imlunestrant Combo Improves PFS in Advanced Breast CancerDecember 11th, 2024
  • Join now to see all